Open Access. Powered by Scholars. Published by Universities.®
- Institution
-
- Seattle University School of Law (202)
- American University Washington College of Law (200)
- University of Michigan Law School (35)
- UIC School of Law (34)
- University of Arkansas, Fayetteville (30)
-
- Cleveland State University (29)
- Schulich School of Law, Dalhousie University (24)
- Yeshiva University, Cardozo School of Law (22)
- Brooklyn Law School (19)
- BLR (16)
- University of Georgia School of Law (15)
- Georgetown University Law Center (14)
- Georgia State University College of Law (14)
- Mitchell Hamline School of Law (14)
- Washington and Lee University School of Law (14)
- SJ Quinney College of Law, University of Utah (13)
- Vanderbilt University Law School (13)
- Pace University (12)
- Penn State Dickinson Law (12)
- Marquette University Law School (11)
- University of Maryland Francis King Carey School of Law (10)
- University of Miami Law School (10)
- Loyola University Chicago, School of Law (9)
- Texas A&M University School of Law (9)
- William & Mary Law School (9)
- Boston University School of Law (8)
- Fordham Law School (8)
- Pepperdine University (8)
- Florida State University College of Law (7)
- University of Richmond (7)
- Keyword
-
- FDA (69)
- Public health (37)
- Regulation (37)
- Food and Drug Law (35)
- Drugs (32)
-
- Health Law and Policy (32)
- Pharmaceuticals (28)
- Food and Drug Administration (27)
- Law (21)
- Environmental law (18)
- Drug (16)
- Marijuana (16)
- Addiction (15)
- Legislation (15)
- Opioid crisis (14)
- Opioids (14)
- Tobacco (13)
- COVID-19 (12)
- Health (12)
- Obesity (12)
- Pharmaceutical (12)
- Cannabis (11)
- Controlled Substances Act (11)
- Federalism (11)
- Medical Jurisprudence (11)
- Science and Technology (11)
- Climate change (10)
- Food (10)
- Health law (10)
- Law and Society (10)
- Publication Year
- Publication
-
- Seattle University Law Review (199)
- Sustainable Development Law & Policy (179)
- Faculty Scholarship (35)
- UIC Law Review (30)
- Journal of Food Law & Policy (29)
-
- Journal of Law and Health (25)
- Articles, Book Chapters, & Popular Press (21)
- Articles (19)
- ExpressO (15)
- Utah Law Review (13)
- Washington and Lee Law Review (11)
- Faculty Publications (10)
- Georgetown Law Faculty Publications and Other Works (10)
- Dickinson Law Review (2017-Present) (9)
- Faculty Publications By Year (9)
- Brooklyn Law Review (8)
- Elisabeth Haub School of Law Faculty Publications (8)
- Fordham Law Review (8)
- William Mitchell Law Review (8)
- Cardozo Law Review (7)
- Scholarly Articles in Law Reviews & Journals (7)
- Scholarly Works (7)
- Scholarship@WashULaw (7)
- Journal of Health Care Law and Policy (6)
- Michigan Law Review (6)
- University of Michigan Journal of Law Reform (6)
- University of Richmond Law Review (6)
- Amicus Briefs & Court Filings (5)
- Brooklyn Journal of International Law (5)
- DePaul Journal of Health Care Law (5)
- Publication Type
Articles 661 - 690 of 992
Full-Text Articles in Food and Drug Law
Editor's Note, Ryan Schmidt, Kimberly Reynolds
Editor's Note, Ryan Schmidt, Kimberly Reynolds
Sustainable Development Law & Policy
No abstract provided.
The Law Of The Seas: A Barrier To Implementation Of Sustainable Development Goal 14, Alexi Nathan
The Law Of The Seas: A Barrier To Implementation Of Sustainable Development Goal 14, Alexi Nathan
Sustainable Development Law & Policy
No abstract provided.
The Key To Engaging With The Sdgs: Utilizing Rio Principle 10 To Succeessfully Implement The U.N. Sustainable Development Goals, Taís Ludwig
Sustainable Development Law & Policy
No abstract provided.
Lofty Goals In Dire Times: South Sudan's Obstacles To Achieving The New Sdgs, Harjot Dhillon
Lofty Goals In Dire Times: South Sudan's Obstacles To Achieving The New Sdgs, Harjot Dhillon
Sustainable Development Law & Policy
No abstract provided.
Developing An International Carbon Tax Regime, Steven Specht
Developing An International Carbon Tax Regime, Steven Specht
Sustainable Development Law & Policy
No abstract provided.
A North-South Struggle: Political And Economic Obstacles To Sustainable Development, Imrana Iqbal, Charles Pierson
A North-South Struggle: Political And Economic Obstacles To Sustainable Development, Imrana Iqbal, Charles Pierson
Sustainable Development Law & Policy
No abstract provided.
Lodging The Sustainable Development Goals In The International Trade Regime: From Trade Rhetoric To Trade Plethoric, Nasser Alreshaid
Lodging The Sustainable Development Goals In The International Trade Regime: From Trade Rhetoric To Trade Plethoric, Nasser Alreshaid
Sustainable Development Law & Policy
No abstract provided.
Editor's Note, Caitlin Buchanan
Editor's Note, Caitlin Buchanan
Sustainable Development Law & Policy
No abstract provided.
How To Combat Prenatal Substance Abuse While Also Protecting Pregnant Women: A Legislative Proposal To Create An Appropriate Balance, Kyle Kennedy
Arkansas Law Review
“Substance abuse in pregnancy is associated with a number of adverse outcomes for the woman, fetus, and neonate.” A recent study indicated that approximately 5.9% of pregnant women between the ages of fifteen and forty-four use illicit drugs. Prenatal illicit drug use has escalated over the past decade, causing an increase in “maternal and neonatal complications, neonatal abstinence syndrome, and health care costs.” Following alcohol and marijuana, methamphetamine is the most commonly abused drug.4 By 2006, admissions for treatment of methamphetamine abuse among pregnant women had increased to twenty-four percent of federally-funded treatment admissions, up from eight percent in 1994.
"Fowl" Practice Of Humane Labeling: Proposed Amendments To Federal Standards Governing Chicken Welfare And Poultry Labeling Practices, Latravia Smith
"Fowl" Practice Of Humane Labeling: Proposed Amendments To Federal Standards Governing Chicken Welfare And Poultry Labeling Practices, Latravia Smith
Alumni Works
Chickens raised specifically for meat production are the world’s most intensively farmed land animals. Yet, the existing legal frameworks that regulate the production and labeling of poultry products in the United States allow poultry producers to mistreat chickens, falsely distinguish poultry products, and defraud conscious consumers. This article proposes unique opportunities to improve poultry welfare in the United States’ agricultural industry and offers methods to ensure the accurate labeling of poultry products.
The Aftermath Of Care V. Cow Palace And The Future Of Rcra In Cafo Cases, Lauren Tavar
The Aftermath Of Care V. Cow Palace And The Future Of Rcra In Cafo Cases, Lauren Tavar
Sustainable Development Law & Policy
No abstract provided.
Water, Water, Nowhere: Adapting Water Rights For A Changing Climate, Caleb Hall
Water, Water, Nowhere: Adapting Water Rights For A Changing Climate, Caleb Hall
Sustainable Development Law & Policy
No abstract provided.
Ridding Pes Systems Of The “Pay To Pollute” Principle: Pes Optimization Strategies, Kelly Carlson
Ridding Pes Systems Of The “Pay To Pollute” Principle: Pes Optimization Strategies, Kelly Carlson
Sustainable Development Law & Policy
No abstract provided.
Indoor Aquaponics In Abandoned Buildings: A Potential Solution To Food Deserts, Lisa Tomlinson
Indoor Aquaponics In Abandoned Buildings: A Potential Solution To Food Deserts, Lisa Tomlinson
Sustainable Development Law & Policy
No abstract provided.
Investing In Resiliency: Prioritizing Water Systems And Investing In Green Infrastructure, Caitlin Cutchin
Investing In Resiliency: Prioritizing Water Systems And Investing In Green Infrastructure, Caitlin Cutchin
Sustainable Development Law & Policy
No abstract provided.
You Probably Shouldn’T Build There: Watershed-Based Land Use Strategies For Mitigating Global Climate Change In New Jersey’S Freshwater Systems, Matthew Knoblauch
You Probably Shouldn’T Build There: Watershed-Based Land Use Strategies For Mitigating Global Climate Change In New Jersey’S Freshwater Systems, Matthew Knoblauch
Sustainable Development Law & Policy
No abstract provided.
Newsroom: Logan Quoted In Bloomberg News On Opiod Litigation 08-16-2017, Jef Feeley, Jared S. Hopkins
Newsroom: Logan Quoted In Bloomberg News On Opiod Litigation 08-16-2017, Jef Feeley, Jared S. Hopkins
Life of the Law School (1993- )
No abstract provided.
Patent Arbitration: The Underutilized Process For Resolving International Patent Disputes In The Pharmaceutical And Biotechnology Industries, Alessandra Emini
Patent Arbitration: The Underutilized Process For Resolving International Patent Disputes In The Pharmaceutical And Biotechnology Industries, Alessandra Emini
Arbitration Law Review (2009 - Present)
No abstract provided.
Big Brother Or Big Pharma: The Lion Fight Over The Surveillance And Promotion Of Pharmaceutical Use In America, Patrick Bailey
Big Brother Or Big Pharma: The Lion Fight Over The Surveillance And Promotion Of Pharmaceutical Use In America, Patrick Bailey
Florida State University Law Review
No abstract provided.
Engaging Health Insurers In The War On Prescription Painkillers, Valarie K. Blake
Engaging Health Insurers In The War On Prescription Painkillers, Valarie K. Blake
Law Faculty Scholarship
No abstract provided.
Circling The Drain: Regulating Nutrient Pollution From Agricultural Sources, William Gutermuth
Circling The Drain: Regulating Nutrient Pollution From Agricultural Sources, William Gutermuth
Journal of Law and Health
The 2014 Toledo, Ohio tap water ban has, at least temporarily, put a spotlight on United States water supplies. Consequently, many Americans have begun to take a closer look at the quality of the fresh water bodies being used to supply tap water to their homes. Therefore, this Note analyzes the problems currently threatening the lakes, rivers, and other surface waters that are the source of fresh drinking water for huge populations in the United States. Part II examines the problem of nutrient pollution and explains the harmful effects it has on human health. Part III provides an overview of …
Weird Science: Frankenstein Foods And States As Laboratories Of Democracy, Jennifer Mcgee
Weird Science: Frankenstein Foods And States As Laboratories Of Democracy, Jennifer Mcgee
Journal of Law and Health
The National Bioengineered Food Disclosure Standard (the 'National Standard') was signed into law July 29, 2016. This Article analyzes the National Standard and posits that Vermont’s Act 120 was a more effective labeling law because it safeguarded consumer sovereignty. The State regulatory scheme in place prior to the passage of the National Standard satisfied consumer demand for disclosure while allowing for necessary experimentation with GMO labeling. Part I provides an overview of the current federal scheme regulating GMOs. Part II analyzes of the conflict surrounding GMOs and labeling. Given that analysis, Part III compares the disclosure requirement of the National …
Pharmaceutical Federalism, Patricia J. Zettler
Pharmaceutical Federalism, Patricia J. Zettler
Faculty Publications By Year
There is growing interest in states regulating pharmaceuticals in ways that challenge the U.S. Food and Drug Administration’s (FDA) federal oversight. For example, in 2013 Maine enacted a law to permit the importation of unapproved drugs, reflecting concerns that federal requirements are too restrictive, while in 2014 Massachusetts banned an FDA-approved painkiller, reflecting concerns that federal requirements are too lax. This Article provides an account of this recent state interest in regulating drugs and considers its consequences. It argues that these state regulatory efforts, and the nascent litigation about them, demonstrate that the preemptive reach of the FDA’s authority extends …
Do Desperate Times Really Call For Desperate Measures? The Ethical Dilemma Behind The Regulation And Use Of Experimental Drugs, Lauren Kuehn
Do Desperate Times Really Call For Desperate Measures? The Ethical Dilemma Behind The Regulation And Use Of Experimental Drugs, Lauren Kuehn
Notre Dame Journal of International & Comparative Law
This Note will argue that, unlike what many patients believe, the U.S. Food and Drug Administration (FDA) plays an invaluable and imperative role in seeking the efficacy and safety of new treatment options and drugs. The balance of interests between those who are terminally ill, who wish to see increased access to unapproved medicines; the general public, who has an interest in preserving the drug approval process; and the FDA, who has been mandated by law to safeguard the safety of the general public, creates a tension that will continue to go unresolved. Thus, the patients who continue to advocate …
Food Date Labels And Hunger In America, Gwen B. Thomson
Food Date Labels And Hunger In America, Gwen B. Thomson
Concordia Law Review
Millions of Americans go hungry, while 40% of the food in the United States is wasted. Research has shown that 43% of the waste occurs in homes and that consumers are making decisions about purchasing and throwing away food without understanding the meaning of the food date labels. One of the most cost-effective ways to begin to effect a change is to eliminate the myriad of confusing food date labels so that individuals do not throw away good food. In May 2016, the Food Date Labeling Act of 2016 was proposed in both houses of Congress. This bicameral bill was …
The Recent Enactment Of National Mandatory Gmo Labeling Law: Superior To A Voluntary Labeling Scheme But Unlikely To End The Labeling Controversy, Nan Feng
Seattle University Law Review
Part I of this Note provides background information about the major controversies related to GM foods, including the debate about whether such foods should be labeled, and the history of GMO labeling laws in the United States. Part II compares S. 764 with H.R. 1599 and explains why a national mandatory labeling approach is superior to the voluntary labeling approach advocated by the House. Part III discusses the potential drawbacks and effect of S. 764 and finally concludes that the rulemaking process that will follow may create controversies and litigation.
The Uncharted Waters Of Competition And Innovation In Biological Medicines, Erika Lietzan
The Uncharted Waters Of Competition And Innovation In Biological Medicines, Erika Lietzan
Florida State University Law Review
In 2010, Congress fundamentally changed how federal law encourages the discovery and development of certain new medicines and for the first time authorized less expensive “duplicates” of these medicines to be approved and compete in the marketplace. The medicines at issue are biological medicines—generally, medicines made from, or grown in, living systems. Many of the world’s most important and most expensive medicines for serious and life-threatening diseases are biological medicines. Today, that law is beginning to bear fruit; FDA has begun to approve the first of these duplicates, called “biosimilars,” and the products have begun to enter the marketplace.
We …